STOCK TITAN

Singularity Future Tech (Nasdaq: SGLY) lands $2M from non-U.S. unit buyers

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Singularity Future Technology Ltd. entered into a securities purchase agreement with certain non-U.S. investors to complete a private placement of 5,263,158 units at $0.38 per Unit, for aggregate gross proceeds of approximately $2,000,000.

Each Unit consists of one share of common stock and three Warrants, for a total of 15,789,474 Warrants. The Warrants are exercisable immediately at an initial exercise price of $0.418 per share, may be exercised cashlessly under specified conditions after one month, and expire five years from issuance. The transaction closed on July 13, 2026, and the shares were issued in reliance on Regulation S exemptions.

Positive

  • None.

Negative

  • None.

Filing Explained

Completed issuance adds dilution for existing holders, while further warrant-related share expansion remains conditional on exercise.

The July 13 Form 8-K, which reports specified material events, states that Singularity Future Technology Ltd. completed on July 13 the private placement agreed on July 6.

The company issued 5,263,158 common shares and 15,789,474 warrants for an aggregate purchase price of approximately $2,000,000.

Issuing the shares increases the total share count and, absent offsetting changes, reduces an existing common holder’s percentage ownership.

The warrants are not shares issued today: they are immediately exercisable for cash at an exercise price of $0.418 per share, expire five years from issuance, and may become eligible for cashless exercise after the one-month anniversary if no effective resale registration statement or current prospectus is available.

The disclosed purchase price was approximately $2,000,000, compared with $2,233,664 of cash and equivalents reported for the quarter ended March 31, 2026.

That latest-quarter cash balance equals 17.8 days of the last reported operating cash use, a historical liquidity comparison rather than a measure of current cash after the completed transaction.

A defined follow-up is whether a resale registration statement or current prospectus is available one month after issuance, because that condition affects the warrants’ cashless-exercise provision.

Sources and calculations
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $2,233,664 / ($11,277,722 / 90) = [object Object]
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Units Sold 5,263,158 units Aggregate units sold in the private placement under the SPA
Unit Price $0.38 per Unit Purchase price per Unit in the private placement
Gross Proceeds approximately $2,000,000 Aggregate purchase price for the Offering
Warrants Issued 15,789,474 Warrants Total number of Warrants issued, three per Unit
Warrant Exercise Price $0.418 per share Initial exercise price of each Warrant for common stock
Warrant Term five years Expiration period from the date of Warrant issuance
Closing Date July 13, 2026 Date on which the Offering consummated
securities purchase agreement financial
"entered into a securities purchase agreement (the “SPA”) with certain investors"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Regulation S regulatory
"non-U.S. Persons as defined in Regulation S of the Securities Act of 1933"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
anti-dilution provisions financial
"The Warrants are subject to customary anti-dilution provisions reflecting capitalizations"
Anti-dilution provisions are contract terms that protect an investor’s percentage ownership when a company issues new shares at a lower price than the investor originally paid. They work like an automatic recalculation of split pieces when a pie gets cut into more slices, preserving the investor’s relative stake and reducing unexpected losses of ownership and voting power, which matters because it affects potential control, future returns, and valuation of an investment.
cashlessly financial
"The Warrants may also be exercised cashlessly if at any time after the one-month anniversary"
unregistered sales of equity securities regulatory
"Item 3.02. Unregistered sales of equity securities."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001422892 0001422892 2026-07-06 2026-07-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 6, 2026

 

SINGULARITY FUTURE TECHNOLOGY LTD.

(Exact name of registrant as specified in its charter)

 

Virginia   001-34024   11-3588546
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

48 Wall Street, Suite 1100
New York, NY 10005

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: 702-849-4548

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, no par value   SGLY   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On July 6, 2026, Singularity Future Technology Ltd. (the “Company”) entered into a securities purchase agreement (the “SPA”) with certain investors, under which the Company agreed to sell to the investors an aggregate of 5,263,158 units (the “Unit”), each Unit consisting of one share of the Company’s common stock, without par value (the “Common Stock”) and three warrants, with each warrant initially exercisable to purchase one share of the Common Stock at an exercise price of $0.418 (the “Warrants”), in a private placement to certain “non-U.S. Persons” as defined in Regulation S of the Securities Act of 1933, as amended (the “Regulation S”), at a price of $0.38 per Unit for an aggregate purchase price of approximately $2,000,000 (the “Offering”).

 

The Warrants are exercisable immediately upon the date of issuance at an initial exercise price of $0.418, for cash. The Warrants may also be exercised cashlessly if at any time after the one-month anniversary of the issuance date, there is no effective registration statement registering, or no current prospectus available for, the resale of the shares of Common Stock underlying the Warrant. The Warrants shall expire five years from its date of issuance. The Warrants are subject to customary anti-dilution provisions reflecting capitalizations and subdivisions or other similar transactions.

 

The parties to the SPA have each made customary representations, warranties and covenants, including, among other things, (a) the Purchasers are “non-U.S. Persons” as defined in Regulation S and are acquiring the Shares for the purpose of investment, (d) the absence of any undisclosed material adverse effects, and (e) the absence of legal proceedings that affect the completion of the transaction contemplated by the Securities Purchase Agreement, except as disclosed in the Company’s filings with the SEC.

 

On July 13, 2026, the Offering consummated upon satisfying the closing conditions as set forth in the SPA, including, among other things, accuracy of the parties’ representations and warranties. The Company issued an aggregate of 5,263,158 shares of Common Stock (the “Shares”) and 15,789,474 Warrants. The Shares were issued in reliance on the exemption from registration provided by the Regulation S.

 

The form of the SPA and the form of the Warrant are attached hereto as Exhibit 10.1 and 10.2 and incorporated herein by reference.

 

Item 3.02. Unregistered sales of equity securities.

 

The disclosure set forth in Item 1.01 above is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Document
10.1   Form of the SPA
10.2   Form of the Warrant
104   Cover Page Interactive Data File the cover page XBRL tags are embedded within the Inline XBRL.

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 13, 2026 Singularity Future Technology Ltd.
     
  By: /s/ Jia Yang
  Name:  Jia Yang
  Title: Chief Executive Officer

 

2

 

Filing Exhibits & Attachments

5 documents